ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 950

$787K Total Retail Price of All Prescriptions

Rank: 11 out of 950

618 Patients Receiving at Least One Drug in Part D
12%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 2,202 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $80 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,379 185 1 2
LEVOTHYROXINE SODIUM 943 72 2 4
AMLODIPINE BESYLATE 781 145 3 5
ALENDRONATE SODIUM 478 77 4 20
POLYETHYLENE GLYCOL 3350 475 48 5 49
LISINOPRIL 338 65 6 3
ATORVASTATIN CALCIUM 278 80 7 12
METFORMIN HCL 256 76 8 7
FAMOTIDINE 239 22 9 84
OMEPRAZOLE 223 26 10 1
ATENOLOL 202 62 11 15
METOPROLOL TARTRATE 196 60 12 10
TAMSULOSIN HCL 184 77 13 11
FLUTICASONE PROPIONATE 182 13 14 25
HYDROCHLOROTHIAZIDE 178 38 15 8
DESMOPRESSIN ACETATE 160 21 16 221
FUROSEMIDE 156 60 17 9
LAMOTRIGINE 155 0 18 62
LACTULOSE 154 24 19 102
LIPITOR 153 22 20 86
ENALAPRIL MALEATE 134 52 21 29
CLOTRIMAZOLE 133 17 22 237
DIVALPROEX SODIUM ER 120 0 23 129
CYPROHEPTADINE HCL 118 0 R 24 283
IBUPROFEN 115 0 25 66
AMMONIUM LACTATE 111 33 26 51
TERAZOSIN HCL 105 27 27 113
DIVALPROEX SODIUM 105 0 27 127
LEVETIRACETAM 101 0 29 67
FINASTERIDE 97 57 30 23
PATANOL 94 0 31 171
METOPROLOL SUCCINATE 91 19 32 13
CIPROFLOXACIN HCL 90 0 33 42
BACLOFEN 88 0 34 133
BENZTROPINE MESYLATE 86 0 R 35 304
MEGESTROL ACETATE 83 0 R 36 229
CALCITONIN-SALMON 83 31 36 215
CICLOPIROX 81 13 38 164
VESICARE 80 27 39 43
SINGULAIR 77 14 40 59
CARAFATE 73 15 41 321
FLUOCINONIDE 73 0 41 101
RANITIDINE HCL 71 15 43 45
ABILIFY 69 0 44 139
CHLORHEXIDINE GLUCONATE 68 0 45 236
DIOVAN 68 24 45 33
JANUVIA 67 0 47 39
RISPERIDONE 62 0 48 114
POTASSIUM CHLORIDE 60 14 49 53
CRESTOR 59 13 50 16
QUETIAPINE FUMARATE 59 0 50 115
SUCRALFATE 57 19 52 241
OXCARBAZEPINE 54 0 53 227
WARFARIN SODIUM 51 17 54 14
PRAVASTATIN SODIUM 50 0 55 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.